Background
Methods
Study population
Data collection
Laboratory test
Data analysis
Ethical consideration
Results
Category | Cases | Sensitive | Drug resistant†
| ||||
---|---|---|---|---|---|---|---|
At least one drug | INH | RIF | EMB | SM | |||
n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | ||
Total | 1824 | 1077(59.05) | 747(40.95) | 524(28.73) | 354(19.41) | 255(13.98) | 535(29.33) |
New cases | 1180 | 793(67.20) | 387(32.80) | 228(19.32) | 112(9.49) | 97(8.22) | 287(24.32) |
Previously treated cases | 644 | 284(44.10) | 360(55.90) | 296(45.96) | 242(37.58) | 158(24.53) | 248(38.51) |
Category | Cases | Drug resistant†
| MDR‡
| |||
---|---|---|---|---|---|---|
HR | HRE | HRS | HRSE | |||
n(%) | n(%) | n(%) | n(%) | n(%) | ||
Total | 1824 | 37(2.03) | 26(1.43) | 94(5.15) | 146(8.00) | 303(16.61) |
New cases | 1180 | 9(0.76) | 5(0.42) | 33(2.80) | 43(3.64) | 90(7.63) |
Previously treated cases | 644 | 28(4.35) | 21(3.26) | 61(9.47) | 103(15.99) | 213(33.07) |
χ
2
| 26.95 | 23.87 | 37.98 | 86.29 | 194.76 | |
P
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
Area of residence | New cases | Previously treated cases | Total | ||||||
---|---|---|---|---|---|---|---|---|---|
Cases | Resistant†
| MDR‡
| Cases | Resistant†
| MDR‡
| Cases | Resistant†
| MDR‡
| |
n(%)> | n(%)> | n(%)> | n(%)> | n(%)> | n(%)> | ||||
South | 489 | 132(26.99) | 24(4.91) | 229 | 125(54.59) | 71(31.00) | 718 | 257(35.79) | 95(13.23) |
Central | 221 | 82(37.10) | 21(9.50) | 122 | 72(59.02) | 42(34.43) | 343 | 154(44.90) | 63(18.37) |
North | 470 | 173(36.81) | 45(9.57) | 293 | 163(55.63) | 100(34.13) | 763 | 336(44.04) | 145(19.00) |
χ
2
| 12.76 | 8.76 | 0.65 | 0.69 | 13.11 | 9.84 | |||
P
|
0.002
|
0.012
| 0.723 | 0.708 |
0.001
|
0.007
|
Factors | Cases | No-MDR†
| MDR†
| cOR(95% CI) ‡
|
P
| aOR(95% CI) * |
P
|
---|---|---|---|---|---|---|---|
n = 1824 | n = 1521, n(%) | n = 303, n(%) | |||||
Sex
| |||||||
Men | 1340 | 1129(84.25) | 211(15.75) | 1 | 1 | ||
Women | 484 | 392(80.99) | 92(19.01) | 1.26(0.96-1.65) | 0.099 | 1.43(0.99-2.06) | 0.058 |
Age (years)
| |||||||
65+ | 547 | 465(85.01) | 82(14.99) | 1 | 1 | ||
55-64 | 298 | 247(82.89) | 51(17.11) | 1.17(0.80-1.72) | 0.418 | 1.11(0.74-1.67) | 0.602 |
45-54 | 276 | 217(78.62) | 59(21.38) | 1.54(1.06-2.24) |
0.022
| 1.53(1.03-2.28) |
0.035
|
35-44 | 270 | 208(77.04) | 62(22.96) | 1.69(1.17-2.44) |
0.005
| 1.88(1.26-2.81) |
0.002
|
25-34 | 188 | 169(89.89) | 19(10.11) | 0.64(0.38-1.08) | 0.095 | 0.87(0.49-1.53) | 0.626 |
< 25 | 245 | 215(87.76) | 30(12.24) | 0.79(0.51-1.24) | 0.306 | 1.38(0.84-2.29) | 0.206 |
Treatment history
#
| |||||||
No | 1180 | 1090(92.37) | 90(7.63) | 1 | 1 | ||
Yes | 644 | 431(66.93) | 213(33.07) | 5.99(4.57-7.84) |
< 0.001
| 6.14(4.61-8.17) |
< 0.001
|
Area of residence
| |||||||
South | 718 | 623(86.77) | 95(13.23) | 1 | 1 | ||
Central | 343 | 280(81.63) | 63(18.37) | 1.48(1.04-2.09) |
0.029
| 1.47(1.01-2.13) |
0.044
|
North | 763 | 618(81.00) | 145(19.00) | 1.54(1.16-2.04) |
0.003
| 1.42(1.05-1.92) |
0.023
|
Cigarette smoking
&
| |||||||
Never | 862 | 706(81.90) | 156(18.10) | 1 | 1 | ||
Ever | 954 | 809(84.80) | 145(15.20) | 0.81(0.63-1.04) | 0.098 | 1.01(0.72-1.42) | 0.942 |